Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
11/2010
11/04/2010WO2010092111A3 Compounds for non-invasive measurement of aggregates of amyloid peptides
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100279311 Method for screening of cell-protecting agent
11/04/2010US20100276672 Organic electroluminescent device and display medium
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN101878219A Imidazolothiadiazoles for use as protein kinase inhibitors
11/03/2010CN101878211A Aminothiazole derivatives
11/03/2010CN101875661A Anti-tumor compound extracted from house lizard as well as preparation method and application thereof
11/02/2010US7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
10/2010
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010122091A1 Thia-triaza-as-indacenes as pi3-kinases inhibitors for the treatment of cancer
10/28/2010WO2010122071A1 Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer
10/28/2010US20100273839 Compounds Having Activity in Correcting Mutant-CFTR Processing and Uses Thereof
10/28/2010US20100273830 Novel insecticides
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273775 Fungicidal bicyclic pyrazoles
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010CA2759595A1 Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer
10/27/2010EP1907399B1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874031A Sirtuin modulating imidazothiazole compounds
10/27/2010CN101874030A Pyrrolidines and piperidines as orexin receptor antagonists
10/27/2010CN101874028A 2-aza-bicyclo[3.3.0]octane derivatives
10/27/2010CN101027309B Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820657 receptor kinase inhibitors such as 3-(2-{4-[3-(5-tert-Butyl-isoxazol-3-yl)-ureido]-phenyl}-benzo[d]imidazo[2,1-b]thiazol-7-yl)-N-(2-morpholin-4-yl-ethyl)-propionamide; flk inhibitors
10/26/2010US7820651 for catheter and port systems, for preventing infections and sepsis
10/21/2010WO2010120621A1 Hepatitis c virus inhibitors
10/21/2010WO2010084499A3 Bicyclic heterocyclic spiro compounds
10/21/2010WO2010008847A3 Pi3k/m tor inhibitors
10/21/2010WO2009020470A3 Cgrp receptor antagonists
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267757 Aminothiazoles and their uses
10/20/2010EP2240467A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP1732929B1 Tricyclic benzopyran compound as anti-arrhythmic agents
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010CN101868465A Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
10/20/2010CN101863908A Oxacyclo-sulfamide spirocyclic medicament template and synthesis method thereof
10/20/2010CN101863886A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816526 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
10/19/2010US7816524 Methods of preparing quinolone analogs
10/19/2010CA2437409C Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/19/2010CA2436589C Heterocyclic compounds and cognitive enhancers comprising the same as effective components
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/14/2010WO2010117662A1 Modulators of s1p and methods of making and using
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010WO2010115623A1 Oligomeric and polymeric semiconductors based on thienothiazoles
10/14/2010WO2010115264A1 Inhibitors of hiv replication
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261710 HDAC Inhibitors
10/14/2010DE102009016502A1 Oligomere und polymere Halbleiter auf Basis von Thienothiazolen Oligomeric and polymeric semiconductors based on Thienothiazolen
10/14/2010CA2758149A1 Inhibitors of hiv replication
10/13/2010EP2238144A1 Compounds comprising a cyclobutoxy group
10/13/2010EP2238142A2 Macrocyclic indoles as hepatitis c virus inhibitors
10/13/2010EP2004658B1 Condensed imidazole derivatives as aromatase inhibitors
10/13/2010EP1899357B1 Pyrido-thiazinium dyes
10/13/2010CN101857602A Preparation method for Prulifloxacin
10/13/2010CN101348496B S-triazolothiadiazole compound, and preparation and use thereof
10/12/2010US7812172 Charge transport materials; for organic electronic devices such as organic photoreceptors, organic electroluminescence devices, organic transistors, and organic optical memories
10/12/2010US7812170 Insecticides
10/12/2010US7812167 Substituted (thiazol-2-yl)-amides or sulfonamides as glucokinase activators useful in the treatment of type 2 diabetes
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7812014 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections
10/12/2010CA2470578C Tetrahydroquinoline analogues as muscarinic agonists
10/07/2010WO2010112874A1 Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
10/07/2010US20100256378 Fluorescent cellular markers
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256124 Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010CA2756873A1 Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
10/06/2010EP2236498A1 Phenyl acetamide derivative
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010CN101855230A Process for the preparation of 6-substituted-imidazo [2,1-b] thiazole-5-sulfonyl halide
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807668 Anti-inflammatory compounds
09/2010
09/30/2010WO2010109328A1 Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
09/30/2010WO2010077852A3 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
09/30/2010US20100249119 Heterocyclic compound and use thereof
09/30/2010US20100249071 Modulators of S1P and Methods of Making And Using
09/30/2010CA2756534A1 Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
09/29/2010EP2233488A1 Thiazolothiazole derivatives and organic electronic device using the same
09/29/2010EP2233474A1 Condensed aminodihydrothiazine derivative
09/29/2010EP2231669A1 Phosphodiesterase inhibitors
09/29/2010EP2231656A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
09/29/2010EP2231653A1 Antibacterial condensed thiazoles
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2004641B1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
09/29/2010EP1638957B1 N-heterocyclyl phenyl-substituted cyclic ketoenols
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 152